OSTX OS Therapies Inc

$OSTX First post on LinkedIn in over 3 weeks. Previously they posted something almost every day. I’ve been looking for a sign of life so this will do for now! 📈

$OSTX The stock price has seemed to have scared off a lot people. But I'm a buyer again at these levels! I added throughout the week and anticipate adding more this coming week . We know the dilution and have a good idea of the company's cash position. There's obvious overhang too but I can be patient. That could all change in the coming days but for now it's all good by me as we head into what should be an interesting November. Know what you own. GLTAL

$OSTX We are quickly approaching a pivotal stretch, and the pieces are lining up. Looking at the calendar: OSTX has reiterated Q4 2026 targets for U.S. BLA and UK/EU/Australia conditional marketing submissions. The FDA Type C meeting is complete, MHRA has aligned on the UK Phase 3 pathway, and the October 19 financing announcement brought in $7.2M gross to help fund operations. RMAT, Rolling Review, the final BLA submission and CNPV decisions remain are all looming as November approaches. The market may be focused on dilution and silence, but the real story is whether OSTX can convert clinical data and regulatory alignment into early market access. The next 8 weeks will be defining. Execution still matters—but this is a company with a real catalyst calendar, not just a speculative narrative. I don’t think it’s an outlandish statement to say that a lot of us will be surprised to not make at LEAST 100% on this in the next couple of months and much more in the months to follow.

$OSTX The market could be reacting to the $1.30 exercise price, the new warrants, or the prospect of additional shares (all 3 probably). All legit technical and valuation considerations. This financing reduces near term liquidity risk, preserves the ATM for potential use at higher valuations. With no new negative clinical or regulatory developments to alter my thesis, I’ve continued adding at these levels.

$OSTX Jason Kolbert from D. Boral Capital has maintained a $20.00 price target with a "Buy" rating for OS Therapies Inc. (OSTX).

$OSTX realize that what was announced yesterday is the equivalent of insider purchases of over 5 million shares at 1.30. And they have the opportunity until October 30 to buy equivalent number of shares at 1.40. I’m sure they were informed more than we have been, what is coming in the next month or so!

$OSTX One thing that deserves more recognition about $OSTX is the company’s track record of being punctual, organized, transparent, and consistent with communications, filings, and stated timelines. They have repeatedly demonstrated that they take their calendar and commitments seriously. That’s why this recent quiet stretch is particularly interesting. When a company that normally communicates consistently goes unusually quiet during such a pivotal regulatory period, it’s reasonable to consider the possibility that significant developments are unfolding behind the scenes. We’re approaching major regulatory and commercialization milestones, yet the price is pinned (warrants/dilution). At approximately $1.15/share, the risk/reward opportunity is almost unbelievable. The market is pricing in the uncertainty caused by the silence, but investors should try not to confuse silence with inactivity. I would encourage you to keep your faith because the company has proven to be worthy of it.

$OSTX has all the science and data lined up and three major drug authorities in the world including FDA are in the process of giving green light to its drug; this will succeed in time. Buy and hold for great reward.

$OSTX Added $5K shares at .81. Had to wait for $$$$ to be transferred so wasnt able to catch it earlier!

$OSTX Still on track for PRV. Nothing changed just a lot of jumpy traders and god awful market. I wish I was someone discovering this today at 80c. What a frickin gift.

$OSTX This sell-off is an overreaction by frustrated shareholders. Do I like it…no. But…been through this before. I believe the science is strong so I am still a buyer.

$OSTX I hope OSTX will give us an INO like surge in the near future! What a mess today. Holding strong.

$OSTX I just bought my last tranche of 5000 shares (at $1.25). I am done buying. Now I hold for good news.

$OSTX People sold because they realized they gotta wait a little longer. Understandable. However, nothing in that press release is bad news. Avoiding Australia to conserve funds is being fiscally responsible.

$OSTX Green finish....short covering helped. Let's hope Monday is the beginning of a long, sustained recovery. Enjoy your weekend.

$OSTX just got of the phone with Paul Romnes, silence was/is because of changing media/ marketing company, moving date for FDA, like it said in PR, because of prolonged test on 10 year product, what is good that it didn't change, that's a big win, financial is pretty good, we can work around and some more coming a little later, FDA it self is a bit messy because they changed some people there, plus summer vacation didn't help. What else 🤔. So far that's all what I can say. Oh UK is going towards approval first and we are really really close.

$OSTX The entire sector looks like it's in full collapse, Nothing has changed...Hold my beer..lol

$OSTX They also explained why they were waiting and why they have to wait for BLA submission. Patience folks, patience. Also rather than them giving another timeline and missing, they are waiting to give the market a proper timeline.

$OSTX Today is October 22. If we go back a full month, management made social media posts (sometimes twice) on the following weekdays: Sept 22, 23, 24, 25, 29, 30, Oct. 1, 2, 5, 6, 7, 8 and 12. Last post on the 12th. An unexplained phenomenon. Feels like an episode of The Twilight Zone!

$OSTX while i would hope the day to day would follow technicals more, aint nothin changed! The man speaks with confidence par excellence.